Your browser doesn't support javascript.
loading
Venous wedge and segment resection during pancreatoduodenectomy for pancreatic cancer: impact on short- and long-term outcomes in a nationwide cohort analysis.
Groen, Jesse V; Michiels, Nynke; van Roessel, Stijn; Besselink, Marc G; Bosscha, Koop; Busch, Olivier R; van Dam, Ronald; van Eijck, Casper H J; Koerkamp, Bas Groot; van der Harst, Erwin; de Hingh, Ignace H; Karsten, Tom M; Lips, Daan J; de Meijer, Vincent E; Molenaar, Isaac Q; Nieuwenhuijs, Vincent B; Roos, Daphne; van Santvoort, Hjalmar C; Wijsman, Jan H; Wit, Fennie; Zonderhuis, Babs M; de Vos-Geelen, Judith; Wasser, Martin N; Bonsing, Bert A; Stommel, Martijn W J; Mieog, J Sven D.
Afiliação
  • Groen JV; Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands.
  • Michiels N; Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands.
  • van Roessel S; Department of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Besselink MG; Department of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Bosscha K; Department of Surgery, Jeroen Bosch Hospital, Den Bosch, the Netherlands.
  • Busch OR; Department of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
  • van Dam R; Department of Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands.
  • van Eijck CHJ; Department of Surgery, Erasmus Medical Centre, Rotterdam, the Netherlands.
  • Koerkamp BG; Department of Surgery, Erasmus Medical Centre, Rotterdam, the Netherlands.
  • van der Harst E; Department of Surgery, Maasstad Hospital, Rotterdam, the Netherlands.
  • de Hingh IH; Department of Surgery, Catharina Hospital, Eindhoven, the Netherlands.
  • Karsten TM; Department of Epidemiology, GROW-School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, the Netherlands.
  • Lips DJ; Department of Surgery, Onze Lieve Vrouwe Gasthuis (loc. Oost), Amsterdam, the Netherlands.
  • de Meijer VE; Department of Surgery, Medisch Spectrum Twente, Enschede, the Netherlands.
  • Molenaar IQ; Department of Surgery, University of Groningen and University Medical Centre Groningen, Groningen, the Netherlands.
  • Nieuwenhuijs VB; Department of Surgery, UMC Utrecht Cancer Centre, St Antonius Hospital Nieuwegein; Regional Academic Cancer Centre Utrecht, Utrecht, the Netherlands.
  • Roos D; Department of Surgery, Isala, Zwolle, the Netherlands.
  • van Santvoort HC; Department of Surgery, Reinier de Graaf Gasthuis, Delft, the Netherlands.
  • Wijsman JH; Department of Surgery, UMC Utrecht Cancer Centre, St Antonius Hospital Nieuwegein; Regional Academic Cancer Centre Utrecht, Utrecht, the Netherlands.
  • Wit F; Department of Surgery, Amphia Hospital, Breda, the Netherlands.
  • Zonderhuis BM; Department of Surgery, Tjongerschans Hospital, Heerenveen, the Netherlands.
  • de Vos-Geelen J; Department of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
  • Wasser MN; Department of Internal Medicine, Division of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht UMC+, Maastricht, the Netherlands.
  • Bonsing BA; Department of Radiology, Leiden University Medical Centre, Leiden, the Netherlands.
  • Stommel MWJ; Department of Surgery, Leiden University Medical Centre, Leiden, the Netherlands.
  • Mieog JSD; Department of Surgery, Radboud University Medical Centre, Nijmegen, the Netherlands.
Br J Surg ; 109(1): 96-104, 2021 12 17.
Article em En | MEDLINE | ID: mdl-34791069
ABSTRACT

BACKGROUND:

Venous resection of the superior mesenteric or portal vein is increasingly performed in pancreatic cancer surgery, whereas results of studies on short- and long-term outcomes are contradictory. The aim of this study was to evaluate the impact of the type of venous resection in pancreatoduodenectomy for pancreatic cancer on postoperative morbidity and overall survival.

METHODS:

This nationwide retrospective cohort study included all patients who underwent pancreatoduodenectomy for pancreatic cancer in 18 centres (2013-2017).

RESULTS:

A total of 1311 patients were included, of whom 17 per cent underwent wedge resection and 10 per cent segmental resection. Patients with segmental resection had higher rates of major morbidity (39 versus 20 versus 23 per cent, respectively; P < 0.001) and portal or superior mesenteric vein thrombosis (18 versus 5 versus 1 per cent, respectively; P < 0.001) and worse overall survival (median 12 versus 16 versus 20 months, respectively; P < 0.001), compared to patients with wedge resection and those without venous resection. Multivariable analysis showed patients with segmental resection, but not those who had wedge resection, had higher rates of major morbidity (odds ratio = 1.93, 95 per cent c.i. 1.20 to 3.11) and worse overall survival (hazard ratio = 1.40, 95 per cent c.i. 1.10 to 1.78), compared to patients without venous resection. Among patients who received neoadjuvant therapy, there was no difference in overall survival among patients with segmental and wedge resection and those without venous resection (median 32 versus 25 versus 33 months, respectively; P = 0.470), although there was a difference in major morbidity rates (52 versus 19 versus 21 per cent, respectively; P = 0.012).

CONCLUSION:

In pancreatic surgery, the short- and long-term outcomes are worse in patients with venous segmental resection, compared to patients with wedge resection and those without venous resection.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article